You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Hyperlipidaemias as a side-effect of drug therapy
- In: Hospital Pharmacy Posters
- At: Hyderabad (India) (2011)
- Type: Poster
- Poster code: HPS-P-20
- By: SKRBO, Selma (Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
- Co-author(s): Skrbo, Armin (Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
Sehovic, Amra (Samed d.o.o., Sarajevo, Bosnia and Herzegovina) - Abstract:
BACKGROUND: Epidemiologic studies have defined lipid disorders as highly significant independent risk factors for coronary heart disease, along with diabetes mellitus, hypertension and smoking. The causes of secondary hyperlipidaemia are generally well known, but not always diagnosed. A large number of drugs can adversely affect serum lipid and..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026